Siemens Healthineers showcases in vitro diagnostic solutions at LMCE 2026

Siemens Healthineers Korea participated in the 2026 International Congress of Laboratory Medicine (LMCE 2026), presenting a range of advanced in vitro diagnostic technologies. The company highlighted its 'FlexLab X' laboratory automation solution, which automates processes from specimen pretreatment to analysis, storage, and additional testing to improve consistency and reduce manual workloads.

The exhibition also featured blood coagulation analyzers, specifically the CN-3000 and CN-6000 models, designed for flexible integration with various laboratory scales. In the Point-of-Care Testing (POCT) sector, the company showcased the RAPIDPoint 500 blood gas analyzer, the epoc blood analysis system, and the Atellica DCA analyzer for diabetes management.

In addition to product displays, a clinical workshop focused on the clinical utility of Enhanced Liver Fibrosis (ELF) testing for non-invasive liver fibrosis assessment. The session addressed the evolving clinical landscape for chronic liver diseases, such as metabolic dysfunction-associated steatohepatitis (MASH).